-
Posted by
Two Blokes Fri at 9:30 AM -
Filed in
Stock
-
2 views
Shares in Oxford BioDynamics PLC (AIM:OBD) rose as much as 9% in early trading on Friday after the company announced that its Oxford-based facility has been accredited by the UK's national accreditation body, enabling it to run its flagship EpiSwitch tests domestically. The laboratory has received ISO 15189 accreditation from the United Kingdom Accreditation Service (UKAS), allowing it to process clinical tests in the UK rather than relying on OBD's US operations.
